424B4424B4
May 26, 2026Final prospectus0001193125-26-239247
All companies
424B4May 26, 2026
Medline Inc. announces launch of secondary offering of Class A common stock
Medline Inc
MDLNPublicArchived
Public / ArchivedUnited States(Nasdaq)Best valuation $45.6B1 market
Public listing
Listed· Nasdaq· Listing market: United StatesListing date
Dec 17, 2025
Offer price
Not available
Shares offered
Not available
Offering proceeds
Not available
Sources: sec-harvest, nasdaq
IPO Calendar · NasdaqIPO
MDLNPrice
$34.71
24h
-3.42%
Valuation
$45.6B
24h volume
$232.3M
Type
IPO
IPO Calendar · updated 1h ago
Medline Inc IPO public float & lock-up
Public float and locked shares extracted from Medline Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Total shares (FD)
875.11M
Public float
72.55M
Locked
802.56M
IPO raise
—
Next unlock
—
Needs review: Could not extract a detailed lock-up release schedule.
Financials
ProfitableFrom SEC filings, latest FY ending Dec 31, 2025 · CIK 0002046386.
Revenue · +11.47% YoY
$28.43B
Net income
$1.16T
Gross margin
26.44%
Cash
$1.94B
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $28.43B | $25.51B | $23.23B |
| Gross profit | $7.52B | $6.98B | $5.89B |
| Operating income | $2.21B | $2.15B | $1.25B |
| Net income | $1.16T | — | — |
| R&D expense | $80M | $67M | $60M |
| Cash & equivalents | $1.94B | $199M | — |
| Total assets | $38.48B | $35.98B | — |
| Total liabilities | $19.2B | $19.45B | — |
| Shareholders' equity | $10.74B | — | — |
About Medline Inc
Medline is a healthcare products and supply-chain company that manufactures, distributes, and supports medical supplies used by hospitals, surgery centers, long-term care facilities, and other providers.
What the company does
- Supplies products across categories such as surgical, exam, infection prevention, lab, protective equipment, and patient-care essentials.
- Combines manufacturing, distribution, logistics, and clinical support services for healthcare organizations.
- Operates in a market where scale, reliability, inventory availability, and customer relationships are critical.
Business profile
Medline is part of the healthcare distribution and medical-products ecosystem, where provider demand and supply-chain execution shape the business.
SEC IPO filings
Final prospectusEDGAR filings resolved from MDLN / CIK 0002046386.
May 21, 2026Effective9999999995-26-001735
S-1S-1
May 20, 2026Filed0001193125-26-231691
Apr 17, 2026Confidential draft0001193125-26-161061
424B4424B4
Mar 6, 2026Final prospectus0001193125-26-096456
Mar 4, 2026Effective9999999995-26-000728
CORRESPfilename1.htm
Mar 3, 2026SEC correspondence0001193125-26-086630
S-1S-1
Mar 3, 2026Filed0001193125-26-086603
UPLOADfilename1.pdf
Feb 12, 2026SEC correspondence0000000000-26-001524
Feb 9, 2026Confidential draft0001193125-26-043051
424B4424B4
Dec 18, 2025Final prospectus0001193125-25-323742
Dec 17, 2025Exchange registration0001354457-25-001276
Latest Medline Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
Medline Newsroom (Medline Inc.)May 20, 2026IPO context
Medline announced that certain selling stockholders affiliated with Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority commenced an underwritten public offering of 60,000,000 shares of Medline Class A common stock, with an intention to grant underwriters an option to buy up to 9,000,000 additional shares; Medline itself is not selling shares and will not receive proceeds. The offering is pursuant to a registration statement filed with the SEC but had not yet become effective at the time of the release.
Medline Inc IPO — frequently asked questions
- When did Medline Inc go public?
- Medline Inc completed its IPO on Dec 17, 2025 on Nasdaq under the ticker MDLN and now trades publicly.
- Can I buy Medline Inc stock?
- Yes — Medline Inc is publicly traded on Nasdaq as MDLN. You can follow its live price, valuation and post-IPO performance above.
- What is Medline Inc's valuation?
- Medline Inc's most recent valuation tracked here is $45.6B, derived from live market prices.